Applied Clinical Trials Editorial Advisory Board and Clinical Trials Professionals Discuss Importance of DIA

September 2, 2014

Applied Clinical Trials

Nancy Dreyer, PhD, MPH, FISPe, discusses the importance of DIA to the industry.




Stewart Geary, MD, discusses how global drug development benefits from DIA.




Michael R. Hamrell, PhD, discusses the impact of DIA on professional development.




Moe Alsumidae discusses how DIA's neutral platform grows industry collaboration and communication.




Tim Callahan, PhD, discusses the scientific benefit of DIA




Related Content:

News